Retraction: Design and validation of ultra-compact metamaterial-based biosensor for non-invasive cervical cancer diagnosis in terahertz regime

Retracted

This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.

PMC · DOI:10.1371/journal.pone.0343674·February 25, 2026

Retraction: Design and validation of ultra-compact metamaterial-based biosensor for non-invasive cervical cancer diagnosis in terahertz regime

PDF

Open Access

Abstract

Linked entities

Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.

Cell lines1

SK— Homo sapiens (Human) · Melanoma · Cancer cell line

Diseases3

BS cervical cancer SL

Peer Reviews

No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.

Videos

No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.

Taxonomy

TopicsTerahertz technology and applications · Metamaterials and Metasurfaces Applications · Plasmonic and Surface Plasmon Research

Full text

The PLOS One Editors retract this article [1] due to concerns about:

We regret that the issues were not identified prior to the publication of [1].

MNH, MTI, SL, and MSI did not agree with the retraction. IuD, BS, and SK either did not respond directly or could not be reached.

Bibliography1

The reference list from the paper itself. Each links out to its DOI / PubMed record.

1Hamza MN, Tariqul Islam M, Lavadiya S, Ud Din I, Sanches B, Koziel S, et al. RETRACTED: Design and validation of ultra-compact metamaterial-based biosensor for non-invasive cervical cancer diagnosis in terahertz regime. P Lo S One. 2025;20(2):e 0311431. doi: 10.1371/journal.pone.0311431 39899558 PMC 11790148 · doi ↗ · pubmed ↗